Literature DB >> 3135470

[Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)].

M Büchler, P Malfertheiner, W Uhl, H R Wolf, G Schwab, H G Beger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135470

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


× No keyword cloud information.
  4 in total

Review 1.  Organ Failure Due to Systemic Injury in Acute Pancreatitis.

Authors:  Pramod K Garg; Vijay P Singh
Journal:  Gastroenterology       Date:  2019-02-12       Impact factor: 22.682

2.  Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections.

Authors:  Pawan Noel; Krutika Patel; Chandra Durgampudi; Ram N Trivedi; Cristiane de Oliveira; Michael D Crowell; Rahul Pannala; Kenneth Lee; Randall Brand; Jennifer Chennat; Adam Slivka; Georgios I Papachristou; Asif Khalid; David C Whitcomb; James P DeLany; Rachel A Cline; Chathur Acharya; Deepthi Jaligama; Faris M Murad; Dhiraj Yadav; Sarah Navina; Vijay P Singh
Journal:  Gut       Date:  2014-12-10       Impact factor: 23.059

Review 3.  Pharmacological interventions for acute pancreatitis.

Authors:  Elisabetta Moggia; Rahul Koti; Ajay P Belgaumkar; Federico Fazio; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

4.  Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study.

Authors:  P Pederzoli; G Cavallini; M Falconi; C Bassi
Journal:  Int J Pancreatol       Date:  1993-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.